Evidence map›Paper›PMID 38076681›Full record

ArticleFrontiers in psychiatry2023

Editorial: Diagnostic and prognostic brain-based biomarkers in psychosis spectrum.

Walid Yassin, Gil D Hoftman, Sarah E Bergen, Elisabetta C Del Re

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cognitive subtypes in youth at clinical high risk for psychosis.Psychiatry and clinical neurosciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Walid YassinDepartment of Psychiatry, Harvard Medical School, Boston, MA, United States.
Gil D HoftmanDepartment of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States.
Sarah E BergenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Elisabetta C Del ReDepartment of Psychiatry, Harvard Medical School, Boston, MA, United States.

Funding

Imaging transcriptomics across developmental stages of early psychotic illnessK23MH129826 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOFTMAN, GIL D · 2023 to 2024
$393k
Identification of Distinct Biotypes in Clinical High Risk for Psychosis State Using Objective Brain-Based BiomarkersR21MH133001 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YASSINE, WALID · 2023 to 2024
$346k
NIMH NIH HHS K23 MH129826NIMH NIH HHS R21 MH133001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersbrainEEGkynurenineMRIpsychosisschizophreniatryptophan

Identifiers

PMID38076681
PMCPMC10703481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.